Portal de Periódicos da CAPES

How Does Parvovirus B19 Dna Achieve Lifelong Persistence in Human Cells?

2017; Future Medicine; Volume: 12; Issue: 10 Linguagem: Inglês

10.2217/fvl-2017-0079

1746-0808

Gloria Bua, Giorgio Gallinella,

Dermatological and COVID-19 studies

Future VirologyVol. 12, No. 10 CommentaryHow does parvovirus B19 DNA achieve lifelong persistence in human cells?Gloria Bua & Giorgio GallinellaGloria Bua Department of Pharmacy & Biotechnology, University of Bologna, Bologna, Italy & Giorgio Gallinella*Author for correspondence: Tel.: +39 051 429 0930; Fax: +39 051 307 397; E-mail Address: giorgio.gallinella@unibo.it Department of Pharmacy & Biotechnology, University of Bologna, Bologna, Italy S.Orsola-Malpighi Hospital – Microbiology, Via Massarenti, 9, I-40138 Bologna, ItalyPublished Online:11 Oct 2017https://doi.org/10.2217/fvl-2017-0079AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: genome expressionparvovirus B19viral persistenceviral pathogenesisReferences1 Gallinella G. Parvovirus B19 achievements and challenges. ISRN Virol. doi:10.5402/2013/898730 (2013) (Epub ahead of print).Crossref, Google Scholar2 Lecuit M, Eloit M. The human virome: new tools and concepts. Trends Microbiol. 21(10), 510–515 (2013).Crossref, Medline, CAS, Google Scholar3 Moustafa A, Xie C, Kirkness E et al. The blood DNA virome in 8,000 humans. PLoS Pathog. 13(3), e1006292 (2017).Crossref, Medline, Google Scholar4 Molenaar-de Backer MW, Russcher A, Kroes AC, Koppelman MH, Lanfermeijer M, Zaaijer HL. Detection of parvovirus B19 DNA in blood: viruses or DNA remnants? J. Clin. Virol. 84, 19–23 (2016).Crossref, Medline, CAS, Google Scholar5 Manning A, Willey SJ, Bell JE, Simmonds P. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus. J. Infect. Dis. 195(9), 1345–1352 (2007).Crossref, Medline, CAS, Google Scholar6 Adamson-Small LA, Ignatovich IV, Laemmerhirt MG, Hobbs JA. Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process. Virus Res. 190, 8–16 (2014).Crossref, Medline, CAS, Google Scholar7 Norja P, Hokynar K, Aaltonen LM et al. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc. Natl Acad. Sci. USA 103(19), 7450–7453 (2006).Crossref, Medline, CAS, Google Scholar8 Toppinen M, Perdomo MF, Palo JU et al. Bones hold the key to DNA virus history and epidemiology. Sci. Rep. 5, 17226 (2015).Crossref, Medline, Google Scholar9 Pyoria L, Toppinen M, Mantyla E et al. Extinct type of human parvovirus B19 persists in tonsillar B cells. Nat. Commun. 8, 14930 (2017).Crossref, Medline, Google Scholar10 Leisi R, Ruprecht N, Kempf C, Ros C. Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism. J. Virol. 87(24), 13161–13167 (2013).Crossref, Medline, CAS, Google Scholar11 Leisi R, Von Nordheim M, Ros C, Kempf C. The VP1u receptor restricts Parvovirus B19 uptake to permissive erythroid cells. Viruses 8(10), (2016).Crossref, Google Scholar12 Munakata Y, Kato I, Saito T, Kodera T, Ishii KK, Sasaki T. Human parvovirus B19 infection of monocytic cell line U937 and antibody-dependent enhancement. Virology 345(1), 251–257 (2006).Crossref, Medline, CAS, Google Scholar13 von Kietzell K, Pozzuto T, Heilbronn R, Grossl T, Fechner H, Weger S. Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q. J. Virol. 88(14), 8102–8115 (2014).Crossref, Medline, CAS, Google Scholar14 Quattrocchi S, Ruprecht N, Bonsch C et al. Characterization of the early steps of human parvovirus B19 infection. J. Virol. 86(17), 9274–9284 (2012).Crossref, Medline, CAS, Google Scholar15 Bua G, Manaresi E, Bonvicini F, Gallinella G. Parvovirus B19 replication and expression in differentiating erythroid progenitor cells. PLoS ONE 11(2), e0148547 (2016).Crossref, Medline, Google Scholar16 Luo Y, Qiu J. Human parvovirus B19: a mechanistic overview of infection and DNA replication. Future Virol. 10(2), 155–167 (2015).Link, CAS, Google Scholar17 Zakrzewska K, Cortivo R, Tonello C et al. Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures. Virus Res. 114(1–2), 1–5 (2005).Crossref, Medline, CAS, Google Scholar18 Janovitz T, Wong S, Young NS, Oliveira T, Falck-Pedersen E.ParvovirusB19 integration into human CD36+ erythroid progenitor cells. Virology 511, 40–48 (2017).Crossref, Medline, CAS, Google Scholar19 Xu H, Hao S, Zhang J, Chen Z, Wang H, Guan W. The formation and modification of chromatin-like structure of human parvovirus B19 regulate viral genome replication and RNA processing. Virus Res. 232, 134–138 (2017).Crossref, Medline, CAS, Google Scholar20 Bonvicini F, Manaresi E, Di Furio F, De Falco L, Gallinella G. Parvovirus b19 DNA CpG dinucleotide methylation and epigenetic regulation of viral expression. PloS ONE 7(3), e33316 (2012).Crossref, Medline, CAS, Google Scholar21 Kerr JR. The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease. J. Clin. Pathol. 69(4), 279–291 (2016).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByNext Generation Sequencing for the Analysis of Parvovirus B19 Genomic Diversity12 January 2023 | Viruses, Vol. 15, No. 1Clinically relevant DNA viruses in pregnancy1 March 2022 | Prenatal DiagnosisA Functional Minigenome of Parvovirus B194 January 2022 | Viruses, Vol. 14, No. 1ParvoviridaeInsights into the knowledge of complex diseases: Environmental infectious/toxic agents as potential etiopathogenetic factors of systemic sclerosisJournal of Autoimmunity, Vol. 124No G-Quadruplex Structures in the DNA of Parvovirus B19: Experimental Evidence versus Bioinformatic Predictions25 August 2020 | Viruses, Vol. 12, No. 9New Insights into Parvovirus Research13 November 2019 | Viruses, Vol. 11, No. 11Advances in the Development of Antiviral Strategies against Parvovirus B1918 July 2019 | Viruses, Vol. 11, No. 7Antiviral activity of brincidofovir on parvovirus B19Antiviral Research, Vol. 162The clinical use of parvovirus B19 assays: recent advances26 July 2018 | Expert Review of Molecular Diagnostics, Vol. 18, No. 9 Vol. 12, No. 10 Follow us on social media for the latest updates Metrics Downloaded 59 times History Published online 11 October 2017 Published in print October 2017 Information© 2017 Future Medicine LtdKeywordsgenome expressionparvovirus B19viral persistenceviral pathogenesisFinancial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download